Supervised injectable heroin treatment is expensive but cost effective, report says
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2942 (Published 23 April 2012) Cite this as: BMJ 2012;344:e2942- Rory Watson
- 1Brussels
Medicinal heroin is being used successfully in several countries as a second line treatment for chronic heroin users previously considered untreatable, says a new report from the European Monitoring Centre for Drugs and Drug Addiction.
The report describes the treatment as “an important clinical step forward” and provides an overview of research on the subject setting out evidence and clinical experience gained in Denmark, Germany, the Netherlands, the United Kingdom, and Switzerland, countries where supervised injectable heroin treatment is legally available to long term, refractory opioid users. In Spain and Canada it may be used in research trials.
Presenting the report, Wolfgang Götz, the centre’s …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.